ABG-WTT Global Life Science Capital Partners GP Ltd Long-Term Concentrated

Name: ABG-WTT Global Life Science Capital Partners GP Ltd Q4 2023 13F Filing | 13F Explorer
Creator: ABG-WTT Global Life Science Capital Partners GP Ltd
Published: 2024-02-14

Location: Central, Hong Kong, Hong Kong

CIK: 0001832108 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value: $51.31M (100.0% shares, 0.0% debt)

Holdings (4)

— RAYZEBIO INC 94.4%

Value $48.43M Shares 778,922 Est. Cost $22.20 Unrealized —

MDVLQ MEDAVAIL HOLDINGS 2.6%

Value $1.35M Shares 300,588 Est. Cost $3.82 Unrealized 0.0%

RPID RAPID MICRO BIOSYSTEMS INC 1.5%

Value $768K Shares 1,038,296 Est. Cost $7.36 Unrealized -86.1%

LUNG PULMONX CORP 1.5%

Value $768K Shares 60,204 Est. Cost $48.97 Unrealized -78.7%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	RAYZEBIO INC	778,922	$48.43M	94.4%	$22.20	—	COM	75525N107
MDVLQ	MEDAVAIL HOLDINGS	300,588	$1.35M	2.6%	$3.82	0.0%	COM NEW	58406B202
RPID	RAPID MICRO BIOSYSTEMS INC	1,038,296	$768K	1.5%	$7.36	-86.1%	CLASS A COM	75340L104
LUNG	PULMONX CORP	60,204	$768K	1.5%	$48.97	-78.7%	COM	745848101